Comparison of characteristics and survival between prospective and retrospective Korea human immunodeficiency virus/Acquired immune deficiency syndrome cohort studies

Jun Hyoung Kim; Yunsu Choi; Joon Young Song; Shin Woo Kim; Sang Il Kim; Mee Kyung Kee; Bo Youl Choi; Jun Yong Choi

doi:10.3947/ic.2019.51.4.393

Comparison of characteristics and survival between prospective and retrospective Korea human immunodeficiency virus/Acquired immune deficiency syndrome cohort studies

Jun Hyoung Kim, Yunsu Choi, Joon Young Song, Shin Woo Kim, Sang Il Kim, Mee Kyung Kee, Bo Youl Choi, Jun Yong Choi

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

By comparing the data of prospectively and retrospectively enrolled cohorts, we evaluated whether the prospective cohort represented all patients in the retrospective cohort. The prospectively enrolled subjects were older and had lower CD4+ T cell counts, higher viral load. In addition, the initial antiretroviral treatment regimen of the prospective cohort consisted of less integrase strand transfer inhibitor-containing regimens. The 20-year survival rate was 51.8% in the prospective cohort and 84.6% in the retrospective cohort, respectively (P = 0.844). This study suggests the prospective cohort study may not represent all patients.

Original language	English
Pages (from-to)	393-398
Number of pages	6
Journal	Infection and Chemotherapy
Volume	51
Issue number	4
DOIs	https://doi.org/10.3947/ic.2019.51.4.393
Publication status	Published - 2019 Dec 1

Bibliographical note

Funding Information:
This study was supported by research grants for deriving the major clinical and epidemiological indicators of HIV-infected people (Korea HIV/AIDS Cohort Study, 2019-ER5101-00) and for the Chronic Infectious Disease Cohort Study (Korea HIV/AIDS Cohort Study, 2013-E51006-00) from the Korea Centers for Disease Control and Prevention.

Funding Information:
This research was supported by a fund of the major clinical and epidemiological indicators of HIV-infected people (Korea HIV/AIDS Cohort Study, 2019-ER5101-00) and for the Chronic Infectious Disease Cohort Study (Korea HIV/ AIDS Cohort Study, 2013-E51006-00) from the Korea Centers for Disease Control and Prevention.

Publisher Copyright:
Copyright © 2019 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.

All Science Journal Classification (ASJC) codes

Infectious Diseases
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3947/ic.2019.51.4.393

Cite this

@article{0e66299177644c868841f8b2270d3dd2,

title = "Comparison of characteristics and survival between prospective and retrospective Korea human immunodeficiency virus/Acquired immune deficiency syndrome cohort studies",

abstract = "By comparing the data of prospectively and retrospectively enrolled cohorts, we evaluated whether the prospective cohort represented all patients in the retrospective cohort. The prospectively enrolled subjects were older and had lower CD4+ T cell counts, higher viral load. In addition, the initial antiretroviral treatment regimen of the prospective cohort consisted of less integrase strand transfer inhibitor-containing regimens. The 20-year survival rate was 51.8% in the prospective cohort and 84.6% in the retrospective cohort, respectively (P = 0.844). This study suggests the prospective cohort study may not represent all patients.",

author = "Kim, {Jun Hyoung} and Yunsu Choi and Song, {Joon Young} and Kim, {Shin Woo} and Kim, {Sang Il} and Kee, {Mee Kyung} and Choi, {Bo Youl} and Choi, {Jun Yong}",

note = "Funding Information: This study was supported by research grants for deriving the major clinical and epidemiological indicators of HIV-infected people (Korea HIV/AIDS Cohort Study, 2019-ER5101-00) and for the Chronic Infectious Disease Cohort Study (Korea HIV/AIDS Cohort Study, 2013-E51006-00) from the Korea Centers for Disease Control and Prevention. Funding Information: This research was supported by a fund of the major clinical and epidemiological indicators of HIV-infected people (Korea HIV/AIDS Cohort Study, 2019-ER5101-00) and for the Chronic Infectious Disease Cohort Study (Korea HIV/ AIDS Cohort Study, 2013-E51006-00) from the Korea Centers for Disease Control and Prevention. Publisher Copyright: Copyright {\textcopyright} 2019 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.",

year = "2019",

month = dec,

day = "1",

doi = "10.3947/ic.2019.51.4.393",

language = "English",

volume = "51",

pages = "393--398",

journal = "Infection and Chemotherapy",

issn = "2093-2340",

publisher = "Taehan Kamyom Hakhoe, Taehan Hwahak Yopop Hakhoe",

number = "4",

}

TY - JOUR

T1 - Comparison of characteristics and survival between prospective and retrospective Korea human immunodeficiency virus/Acquired immune deficiency syndrome cohort studies

AU - Kim, Jun Hyoung

AU - Choi, Yunsu

AU - Song, Joon Young

AU - Kim, Shin Woo

AU - Kim, Sang Il

AU - Kee, Mee Kyung

AU - Choi, Bo Youl

AU - Choi, Jun Yong

N1 - Funding Information: This study was supported by research grants for deriving the major clinical and epidemiological indicators of HIV-infected people (Korea HIV/AIDS Cohort Study, 2019-ER5101-00) and for the Chronic Infectious Disease Cohort Study (Korea HIV/AIDS Cohort Study, 2013-E51006-00) from the Korea Centers for Disease Control and Prevention. Funding Information: This research was supported by a fund of the major clinical and epidemiological indicators of HIV-infected people (Korea HIV/AIDS Cohort Study, 2019-ER5101-00) and for the Chronic Infectious Disease Cohort Study (Korea HIV/ AIDS Cohort Study, 2013-E51006-00) from the Korea Centers for Disease Control and Prevention. Publisher Copyright: Copyright © 2019 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - By comparing the data of prospectively and retrospectively enrolled cohorts, we evaluated whether the prospective cohort represented all patients in the retrospective cohort. The prospectively enrolled subjects were older and had lower CD4+ T cell counts, higher viral load. In addition, the initial antiretroviral treatment regimen of the prospective cohort consisted of less integrase strand transfer inhibitor-containing regimens. The 20-year survival rate was 51.8% in the prospective cohort and 84.6% in the retrospective cohort, respectively (P = 0.844). This study suggests the prospective cohort study may not represent all patients.

AB - By comparing the data of prospectively and retrospectively enrolled cohorts, we evaluated whether the prospective cohort represented all patients in the retrospective cohort. The prospectively enrolled subjects were older and had lower CD4+ T cell counts, higher viral load. In addition, the initial antiretroviral treatment regimen of the prospective cohort consisted of less integrase strand transfer inhibitor-containing regimens. The 20-year survival rate was 51.8% in the prospective cohort and 84.6% in the retrospective cohort, respectively (P = 0.844). This study suggests the prospective cohort study may not represent all patients.

UR - http://www.scopus.com/inward/record.url?scp=85078169022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078169022&partnerID=8YFLogxK

U2 - 10.3947/ic.2019.51.4.393

DO - 10.3947/ic.2019.51.4.393

M3 - Article

AN - SCOPUS:85078169022

SN - 2093-2340

VL - 51

SP - 393

EP - 398

JO - Infection and Chemotherapy

JF - Infection and Chemotherapy

IS - 4

ER -

Comparison of characteristics and survival between prospective and retrospective Korea human immunodeficiency virus/Acquired immune deficiency syndrome cohort studies

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this